RARE

Ultragenyx Pharm

• Simply Wall St·1d ago

  Ultragenyx Pharmaceutical (RARE) Is Up 6.5% After FDA Accepts UX111 BLA Resubmission for Review

• Simply Wall St·2d ago

  Is Ultragenyx Pharmaceutical (RARE) Now Attractive After Recent 8.1% Weekly Share Price Jump

• TipRanks·2d ago

  RBC Capital Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

• NASDAQ·3d ago

  Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates

• Simply Wall St·3d ago

  A Look At Ultragenyx Pharmaceutical (RARE) Valuation After FDA Acceptance Of UX111 Resubmitted BLA

• PR Newswire·5d ago

  RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm

• PR Newswire·5d ago

  Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE

• PR Newswire·6d ago

  RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

• PR Newswire·04/03 13:43

  DEADLINE NEXT WEEK: Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investors to Contact the Firm Before April 6, 2026

• Simply Wall St·04/03 03:37

  Why Ultragenyx Pharmaceutical (RARE) Is Up 12.2% After FDA Accepts UX111 Gene Therapy BLA Review

• TipRanks·04/03 02:04

  Ultragenyx Insider Move: CFO’s Stock Sale Sparks Fresh Investor Buzz

• Reuters·04/02 15:48

  BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford

• Reuters·04/02 14:31

  BUZZ-Ultragenyx rises after FDA accepts marketing application for rare disease therapy

• TipRanks·04/02 13:44

  Ultragenyx BLA for UX111 Accepted for FDA Review

• Seeking Alpha·04/02 13:31

  Ultragenyx says gene therapy accepted for FDA review again